Interleukin 6-guided Antibiotic Prescriptions in AECOPD Inpatients
Status:
NOT_YET_RECRUITING
Trial end date:
2026-08-31
Target enrollment:
Participant gender:
Summary
In this multicenter, prospective, randomized controlled study, we aimed to figure out, compared with the global chronic obstructive pulmonary disease initiative (GOLD) guideline -guided antibiotic therapy, whether Interleukin 6 (IL6)-guided antibiotic therapy for acute exacerbation of chronic obstructive pulmonary disease (AECOPD) can lead to a reduction in the use of antibiotics without increasing the rate of treatment failure.